CoChat
Sign Up
Cited by 52

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Growth hormone‐releasing hormone effects on brain γ‐aminobutyric acid levels in mild cognitive impairment and healthy aging

Friedman, Seth D., Baker, Laura D., Borson, Soo, Jensen, J. Eric, Barsness, Suzanne M., Craft, Suzanne, Merriam, George R., Otto, Randolph K., Novotny, Edward J., Vitiello, Michael V.·2013·JAMA Neurology
DOI 10.1001/jamaneurol.2013.1425PMC PMC3764915
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2013.1425

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 46

  1. [1]Lieberman SA Hoffman AR The somatopause: should growth hormone deficiency in older people be treated? Clin Geriatr Med 1997 13 4 671 684 9354748
  2. [3]Donahue CP Kosik KS Shors TJ Growth hormone is produced within the hippocampus where it responds to age, sex, and stress Proc Natl Acad Sci U S A 2006 103 15 6031 6036 16574776 PMC1420633
  3. [4]Merriam GR Schwartz RS Vitiello MV Growth hormone-releasing hormone and growth hormone secretagogues in normal aging Endocrine 2003 22 1 41 48 14610297
  4. [5]Merriam GR Buchner DM Prinz PN Schwartz RS Vitiello MV Potential applications of GH secretagogs in the evaluation and treatment of the age-related decline in growth hormone secretion Endocrine 1997 7 1 49 52 9449031
  5. [6]Lichtenwalner RJ Forbes ME Bennett SA Lynch CD Sonntag WE Riddle DR Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis Neuroscience 2001 107 4 603 613 11720784
  6. [7]Markowska AL Mooney M Sonntag WE Insulin-like growth factor-1 ameliorates age-related behavioral deficits Neuroscience 1998 87 3 559 569 9758223
  7. [8]Ramsey MM Weiner JL Moore TP Carter CS Sonntag WE Growth hormone treatment attenuates age-related changes in hippocampal short-term plasticity and spatial learning Neuroscience 2004 129 1 119 127 15489035
  8. [9]Thornton PL Ingram RL Sonntag WE Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory J Gerontol A Biol Sci Med Sci 2000 55 2 B106 B112 10737685
  9. [10]Baum HB Katznelson L Sherman JC Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency J Clin Endocrinol Metab 1998 83 9 3184 3189 9745423
  10. [11]Deijen JB de Boer H Blok GJ van der Veen EA Cognitive impairments and mood disturbances in growth hormone deficient men Psychoneuroendocrinology 1996 21 3 313 322 8817729
  11. [12]Papadakis MA Grady D Black D Growth hormone replacement in healthy older men improves body composition but not functional ability Ann Intern Med 1996 124 8 708 716 8633830
  12. [13]Soares CN Musolino NR Cunha Neto M Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults: a placebo-controlled trial Arq Neuropsiquiatr 1999 57 2A 182 189 10412515
  13. [14]Friedlander AL Butterfield GE Moynihan S One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women J Clin Endocrinol Metab 2001 86 4 1496 1503 11297574
  14. [15]Baker LD Barsness SM Borson S Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial Arch Neurol 2012 69 11 1420 1429 22869065 PMC3764914
  15. [16]Vitiello MV Moe KE Merriam GR Mazzoni G Buchner DH Schwartz RS Growth hormone releasing hormone improves the cognition of healthy older adults Neurobiol Aging 2006 27 2 318 323 16399214
  16. [17]Deak F Sonntag WE Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1 J Gerontol A Biol Sci Med Sci 2012 67 6 611 625 22503992 PMC3348499
  17. [18]Arwert LI Veltman DJ Deijen JB Lammertsma AA Jonker C Drent ML Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study Neuroendocrinology 2005 81 1 31 40 15809510
  18. [19]van Dam PS de Winter CF de Vries R Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate Psychoneuroendocrinology 2005 30 4 357 363 15694115
  19. [20]Jensen JE Licata SC Ongür D Quantification of J-resolved proton spectra in two-dimensions with LC Model using GAMMA-simulated basis sets at 4 Tesla NMR Biomed 2009 22 7 762 769 19388001
  20. [21]Edden RA Muthukumaraswamy SD Freeman TC Singh KD Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex J Neurosci 2009 29 50 15721 15726 20016087 PMC6666191
  21. [22]Novotny EJ Jr Hyder F Shevell M Rothman DL GABA changes with vigabatrin in the developing human brain Epilepsia 1999 40 4 462 466 10219272
  22. [24]Baker LD Cross DJ Minoshima S Belongia D Watson GS Craft S Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes Arch Neurol 2011 68 1 51 57 20837822 PMC3023149
  23. [25]Drzezga A Lautenschlager N Siebner H Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study Eur J Nucl Med Mol Imaging 2003 30 8 1104 1113 12764551
  24. [26]Ishiwata A Sakayori O Minoshima S Mizumura S Kitamura S Katayama Y Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study Acta Neurol Scand 2006 114 2 91 96 16867030
  25. [27]Minoshima S Giordani B Berent S Frey KA Foster NL Kuhl DE Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease Ann Neurol 1997 42 1 85 94 9225689
  26. [28]Petersen RC Mild cognitive impairment as a diagnostic entity J Intern Med 2004 256 3 183 194 15324362
  27. [29]Stanley TL Chen CY Branch KL Makimura H Grinspoon SK Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men J Clin Endocrinol Metab 2011 96 1 150 158 20943777 PMC3038486
  28. [30]Edden RA Pomper MG Barker PB In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla Magn Reson Med 2007 57 6 977 982 17534922
  29. [33]Huang W Alexander GE Chang L Brain metabolite concentration and dementia severity in Alzheimer’s disease: a 1H MRS study Neurology 2001 57 4 626 632 11524470
  30. [34]Kantarci K Jack CR Jr Xu YC Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: a 1H MRS study Neurology 2000 55 2 210 217 10908893 PMC2771162
  31. [35]Kantarci K Lowe V Przybelski SA Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults Neurology 2011 77 10 951 958 21865577 PMC3171960
  32. [36]Rossignol E Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders Neural Plast 2012 2011 649325 10.1155/2011/649325 21876820 PMC3159129 · DOI
  33. [37]Neale JH Olszewski RT Zuo D Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family J Neurochem 2011 118 4 490 498 21644997 PMC3137677
  34. [38]Passani LA Vonsattel JP Carter RE Coyle JT N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer’s diseases Mol Chem Neuropathol 1997 31 2 97 118 9376025
  35. [39]Lodder-Gadaczek J Becker I Gieselmann V Wang-Eckhardt L Eckhardt M N-acetyl aspartylglutamatesynthetase II synthesizes N-acetylaspartylglutamylglutamate J Biol Chem 2011 286 19 16693 16706 21454531 PMC3089511
  36. [40]Ling LL Hughes LF Caspary DM Age-related loss of the GABA synthetic enzyme glutamic acid decarboxylase in rat primary auditory cortex Neuroscience 2005 132 4 1103 1113 15857714
  37. [41]Majdi M Ribeiro-da-Silva A Cuello AC Variations in excitatory and inhibitory postsynaptic protein content in rat cerebral cortex with respect to aging and cognitive status Neuroscience 2009 159 2 896 907 19105974
  38. [42]Tanaka DH Toriumi K Kubo K Nabeshima T Nakajima K GABAergic precursor transplantation into the prefrontal cortex prevents phencyclidine-induced cognitive deficits J Neurosci 2011 31 40 14116 14125 21976496 PMC6623672
  39. [43]Fujiwara H Zheng M Miyamoto A Hoshino O Insufficient augmentation of ambient GABA responsible for age-related cognitive deficit Cogn Process 2011 12 2 151 159 21046192
  40. [44]Boy F Evans CJ Edden RA Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity Biol Psychiatry 2011 70 9 866 872 21757187 PMC3192031
  41. [45]Goto N Yoshimura R Kakeda S Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia Hum Psychopharmacol 2009 24 8 639 645 19946939
  42. [46]Henry ME Lauriat TL Shanahan M Renshaw PF Jensen JE Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla J Magn Reson 2011 208 2 210 218 21130670 PMC4641575
  43. [47]Muthukumaraswamy SD Edden RA Jones DK Swettenham JB Singh KD Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans Proc Natl Acad Sci U S A 2009 106 20 8356 8361 19416820 PMC2688873
  44. [48]Boy F Evans CJ Edden RA Singh KD Husain M Sumner P Individual differences in subconscious motor control predicted by GABA concentration in SMA Curr Biol 2010 20 19 1779 1785 20888227 PMC3128986
  45. [49]Puts NA Edden RA Evans CJ McGlone F McGonigle DJ Regionally specific human GABA concentration correlates with tactile discrimination thresholds J Neurosci 2011 31 46 16556 16560 22090482 PMC3374929
  46. [50]Sumner P Edden RA Bompas A Evans CJ Singh KD More GABA, less distraction: a neurochemical predictor of motor decision speed Nat Neurosci 2010 13 7 825 827 20512136

Cited by

Sorted by citations

See all 52

Metadata

Authors
Friedman, S. D., Baker, L. D., Borson, S., Jensen, J. E., Barsness, S. M., Craft, S., Merriam, G. R., Otto, R. K., Novotny, E. J., & Vitiello, M. V.
Venue
JAMA Neurology
Publisher
American Medical Association (AMA)
Published
2013-07-01
Volume
70
Issue
7
Pages
883
ISSN
2168-6149
DOI
10.1001/jamaneurol.2013.1425
PMC
PMC3764915
Cited by
52
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review